TNF and bacterial infectious disease: SET-M33 is already known to abate TNF-α production in vitro in cells stimulated with LPS from P. aeruginosa and K. pneumoniae (9), but nothing was published regarding its inhibitory effect on other cytokines and enzymes that together establish inflammatory processes triggered by bacterial infection.